FDA inspection
Becton, Dickinson and Company, BD Biosciences: FDA inspection ending Nov 28, 2017
FDA inspection 1041888 · No Action Indicated (NAI) · San Jose, CA
Key facts
| Inspection ID | 1041888 |
|---|---|
| Firm | Becton, Dickinson and Company, BD Biosciences |
| FEI number | 2916837 |
| Address | 2350 Qume Dr |
| City | San Jose |
| State | CA |
| ZIP | 95131 |
| Country | United States |
| Fiscal year | 2018 |
| Inspection end date | Nov 28, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data